{
    "code": "02024995",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024995",
    "time": "2023-12-07 21:02:34",
    "許可證字號": "衛署藥輸字第024995號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/03\/24",
    "發證\/登錄日期": "98\/03\/24",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202499507",
    "中文品名": "利瑞卡膠囊 75 毫克",
    "英文品名": "Lyrica hard Capsule 75mg",
    "適應症": "帶狀泡疹後神經痛。成人局部癲癇的輔助治療。纖維肌痛(fibromyalgia)。糖尿病周邊神經病變引起的神經性疼痛。脊髓損傷所引起的神經性疼痛。",
    "劑型": "130膠囊劑",
    "包裝": "4~1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PREGABALIN",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "暉致醫藥股份有限公司",
    "申請商地址": "臺北市信義區信義路５段7號27樓",
    "主製造廠": [
        {
            "製造廠名稱": "Pfizer Manufacturing Deutschland GmBH",
            "製造廠廠址": "Betriebsstatte Freiburg Mooswaldallee 1, 79090 Freiburg, Germany",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812009200",
            "成分名稱": "PREGABALIN",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Lyrica 75mg_藥物外觀-111-04-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=003&Type=10"
        },
        {
            "title": "Lyrica 75 mg外觀-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "上傳TFDA_PAA189588_1_v1_FVID1215002-112-05-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=019&Type=9"
        },
        {
            "title": "Lyrica Capsules 75mg, 150mg, 300mg LLD USPI 202006-2-111-04-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=018&Type=9"
        },
        {
            "title": "024997-109-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=017&Type=9"
        },
        {
            "title": "Lyrica 75mg_外盒鋁箔-111-04-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=004&Type=8"
        },
        {
            "title": "20210809_Lyrica75mg-110-08-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=003&Type=8"
        },
        {
            "title": "Lyrica 75 mg外盒-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024995&Seq=002&Type=8"
        }
    ]
}